E
FPRX

Ergoteles’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Ergoteles’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-231,646
Closed -$8.73M – 1792
2021
Q1 		$8.73M Buy
+231,646
New +$5.78M 0.27% 94

Ergoteles's FPRX Position: Q2 2021 in Review

Ergoteles sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 231,646 shares — an estimated $8.73M sold.

Ergoteles first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $8.73M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Ergoteles reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Ergoteles sold 231,646 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $8.73M.
  • Ergoteles first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • Ergoteles's Five Prime Therapeutics, Inc. position peaked at $8.73M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.